Stephens Consulting, LLC Evolus, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 320 shares of EOLS stock, worth $3,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
320
Previous 290
10.34%
Holding current value
$3,452
Previous $3.2 Million
20.24%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
168Shares Held
48.9MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$55.5 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$53.9 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$43.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$34.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$33.8 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $605M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...